2019
DOI: 10.3748/wjg.v25.i35.5344
|View full text |Cite
|
Sign up to set email alerts
|

Feasibility of endoscopic treatment and predictors of lymph node metastasis in early gastric cancer

Abstract: BACKGROUNDEndoscopic submucosal dissection (ESD) has been routinely performed in applicable early gastric cancer (EGC) patients as an alternative to conventional surgical operations that involve lymph node dissection. The indications for ESD have been recently expanded to include larger, ulcerated, and undifferentiated mucosal lesions, and differentiated lesions with slight submucosal invasion. The risk of lymph node metastasis (LNM) is the most important consideration when deciding on a treatment strategy for… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

5
21
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
6
3

Relationship

1
8

Authors

Journals

citations
Cited by 29 publications
(26 citation statements)
references
References 28 publications
5
21
0
Order By: Relevance
“…Similarly, Japanese Gastric Cancer Association (JGCA) points that nonulcerated, well-differentiated and lesions diameter less than 2 cm are the indications for EMR/EDS approach in EGC patients [24]. Additionally, our study also found that the invasive depth of EGC(T stage) and vascular invasion were also associated with lymph node metastasis, Chu YN et al also found that submucosal invasion depth and LVI were the predictive factors for lymph node metastasis [25], hence, it is truely for the application of ultrasound gastroscope to identify the invasive depths in EGC patients, which could not only measured the lesion size, but also measured the invasive depths of EGC tumors [26]. In collaboration with previous studies, our research indicated that tumor size ≤ 1.9 cm, ultrasound gastroscope presents the non-submucosa invasion and non-vascular invasion might be the indications for ESD/EMR in EGC patients.…”
Section: Discussionsupporting
confidence: 76%
“…Similarly, Japanese Gastric Cancer Association (JGCA) points that nonulcerated, well-differentiated and lesions diameter less than 2 cm are the indications for EMR/EDS approach in EGC patients [24]. Additionally, our study also found that the invasive depth of EGC(T stage) and vascular invasion were also associated with lymph node metastasis, Chu YN et al also found that submucosal invasion depth and LVI were the predictive factors for lymph node metastasis [25], hence, it is truely for the application of ultrasound gastroscope to identify the invasive depths in EGC patients, which could not only measured the lesion size, but also measured the invasive depths of EGC tumors [26]. In collaboration with previous studies, our research indicated that tumor size ≤ 1.9 cm, ultrasound gastroscope presents the non-submucosa invasion and non-vascular invasion might be the indications for ESD/EMR in EGC patients.…”
Section: Discussionsupporting
confidence: 76%
“…16,17 Since the rate of LNM was approximately 14% in previous studies, radical surgery may be excessive in the large proportion of patients without LNM. [18][19][20] Gastrectomy often results in considerable postoperative complications, such as abdominal pain, nausea, vomiting, and dumping syndrome. 21 As endoscopic resection is considered a curative form of resection, it is recommended as an alternative to radical surgery under specific conditions.…”
Section: Discussionmentioning
confidence: 99%
“…In previous studies, depth of infiltration was also considered to be extremely relevant to LNM. 8,20,23,28,29 Some studies reported that, although the mucosa showed an enrichment of blood capillaries, lymphatic ducts were only abundant in the deeper lamina propria and submucosa. 30,31 This may explain the relationship between LNM and depth of invasion.…”
Section: Discussionmentioning
confidence: 99%
“…Lymph node metastasis is a major factor in the endoscopic treatment and prognosis of EGC patients [23,24]. In this study, we found that the lymph node metastasis rate of stage T1 gastric cancer after surgical resection was 14.5% (333/2294).…”
Section: Discussionmentioning
confidence: 67%